Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03240419 · ClinicalTrials.gov registry record · NA

Prenatal Probiotic Intervention

A NA study, sponsored by Arkansas Children's Hospital Research Institute.

Completed
Registry status
NA
Development phase
60
Enrollment target

NCT03240419 is a NA study that has completed, run by Arkansas Children's Hospital Research Institute. The registered enrollment target is 60 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03240419, a NA study, has completed, sponsored by Arkansas Children's Hospital Research Institute.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

This study will assess the feasibility of a randomized control trial in which the effects of probiotic supplementation throughout pregnancy on maternal insulin sensitivity and inflammation, as well offspring gene expression and body composition are examined.

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Probiotics

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2017-08-23
Est. Completion 2019-03-26
Phase NA

What the Registry Record Tells You About NCT03240419

The ClinicalTrials.gov registry entry for NCT03240419 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Arkansas Children's Hospital Research Institute, which has 97 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT03240419 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03240419 about?

NCT03240419 is a clinical study titled "Prenatal Probiotic Intervention". This study will assess the feasibility of a randomized control trial in which the effects of probiotic supplementation throughout pregnancy on maternal insulin sensitivity and inflammation, as well offspring gene expression and body composition are examined.

What is the current status of trial NCT03240419?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2017-08-23. Estimated completion is 2019-03-26.

What interventions are being tested in trial NCT03240419?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Probiotics (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03240419?

This trial is sponsored by Arkansas Children's Hospital Research Institute, which has 97 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.